Haiyung Cheng

发表

Mean Residence Time of Oral Drugs Undergoing First-Pass and Linear Reversible Metabolism

W. Jusko, Haiyung Cheng, 2004, Pharmaceutical Research.

Pharmacokinetics of reversible metabolic systems

W. Jusko, Haiyung Cheng, 1993, Biopharmaceutics & drug disposition.

Mean Residence Time Concepts for Pharmacokinetic Systems with Nonlinear Drug Elimination Described by the Michaelis–Menten Equation

W. Jusko, Haiyung Cheng, 1988, Pharmaceutical Research.

Uptake and Stereoselective Binding of the Enantiomers of MK-927, a Potent Carbonic Anhydrase Inhibitor, by Human Erythrocytes in Vitro

Jiunn H. Lin, Haiyung Cheng, Tsu-Han Lin, 1992, Pharmaceutical Research.

Evaluation of Sustained/Controlled-Release Dosage Forms of 3-Hydroxy-3-methylglutaryl–Coenzyme A (HMG-CoA) Reductase Inhibitors in Dogs and Humans

K. Grasing, J. Schwartz, D. Ebel, 1993, Pharmaceutical Research.

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

B. Gertz, J. Leff, W. Malbecq, 1996, Pharmaceutical Research.

Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding

W. Gillespie, Haiyung Cheng, 1996, Journal of Pharmacokinetics and Biopharmaceutics.

An area function method for calculating the apparent elimination rate constant of a metabolite

W. Jusko, Haiyung Cheng, 1989, Journal of Pharmacokinetics and Biopharmaceutics.

Mean Residence Times and Distribution Volumes for Drugs Undergoing Linear Reversible Metabolism and Tissue Distribution and Linear or Nonlinear Elimination from the Central Compartments

W. Jusko, Haiyung Cheng, 1991, Pharmaceutical Research.

Constant-Rate Intravenous Infusion Methods for Estimating Steady-State Volumes of Distribution and Mean Residence Times in the Body for Drugs Undergoing Reversible Metabolism

W. Jusko, Haiyung Cheng, 1990, Pharmaceutical Research.

Mean residence time concepts for non‐linear pharmacokinetic systems

W. Jusko, W. Gillespie, Haiyung Cheng, 1994, Biopharmaceutics & drug disposition.

A method for calculating the mean absorption time of drugs undergoing reversible and first‐pass metabolism

L. Shum, Haiyung Cheng, 1993, Biopharmaceutics & drug disposition.

Pharmacokinetics and Bioinversion of Ibuprofen Enantiomers in Humans

J. Seibold, S. Holland, Haiyung Cheng, 1994, Pharmaceutical Research.

Pharmacokinetics of 5,6-dihydro-5-azacytidine (NSC-264880) in the foxhound

L. Malspeis, A. Staubus, Haiyung Cheng, 2004, Investigational New Drugs.

Mean Residence Time of Drugs Showing Simultaneous First-Order and Michaelis–Menten Elimination Kinetics

W. Jusko, Haiyung Cheng, 1989, Pharmaceutical Research.

Pharmacokinetics of Linear Reversible Metabolic Systems

W. Jusko, Haiyung Cheng, 1991 .

Pharmacokinetics and bioavailability of montelukast sodium (MK‐0476) in healthy young and elderly volunteers

M. Merz, M. Seiberling, Jamie J. Zhao, 1997, Biopharmaceutics & drug disposition.

Absorbance Ratio Plots in High Performance Liquid Chromatography: Some Software Problems and Remedies

R. Gadde, Haiyung Cheng, 1985 .

Stability-indicating high-performance liquid chromatographic assay for lactic acid in lotions

R. Gadde, Haiyung Cheng, 1986 .

Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics

Daniel E. Salazar, William J. Jusko, W. Jusko, 1991, Journal of Pharmacokinetics and Biopharmaceutics.

Mean residence time of drugs administered non‐instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non‐linear elimination from the central compartment

Haiyung Cheng, H. Cheng, 1995, Biopharmaceutics & drug disposition.

An algorithm and computer program for calculating the mean transit time and distribution rate parameters of generated metabolites undergoing linear tissue distribution and linear or non‐linear central elimination

W. Jusko, Haiyung Cheng, Chi Yu, 1994, Biopharmaceutics & drug disposition.

A method for calculating the mean transit times and distribution rate parameters of interconversion metabolites

Haiyung Cheng, H. Cheng, 1993, Biopharmaceutics & drug disposition.

A general method for calculating the mean transit times and distribution rate parameters of catenary metabolites

Haiyung Cheng, 1992, Biopharmaceutics & drug disposition.

A method for calculating the mean residence times of catenary metabolites

Haiyung Cheng, 1991, Biopharmaceutics & drug disposition.

Effects of Variation in Drug Elimination on Five Methods for Assessing Zero-Order Drug Absorption Rates

W. Jusko, Haiyung Cheng, 2004, Pharmaceutical Research.

A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note

H. Kung, M. Kung, D. Mozley, 1993, European Journal of Nuclear Medicine.

Influence of Age and Gender on the Plasma Profiles of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitory Activity Following Multiple Doses of Lovastatin and Simvastatin

E. Stein, H. Quan, M. Dobrinska, 1992, Pharmaceutical Research.

Mean Interconversion Times and Distribution Rate Parameters for Drugs Undergoing Reversible Metabolism

W. Jusko, Haiyung Cheng, 1990, Pharmaceutical Research.

Gas Chromatographic–Mass Spectrometric (GC-MS) Determination of MDL 72,222 and Four Metabolites in Monkey Plasma

Haiyung Cheng, J. A. Ragner, 1991, Pharmaceutical Research.